Physician

Andrew Mark Davisson, M.D.

According to 2025 Medicare claims, Andrew Davisson, M.D. (NPI: 1912385196) practices physical medicine and rehabilitation in the Muncie, IN market, with the plurality of this provider's patient population coming from Delaware, IN. This provider's primary affiliated billing organization is NEW CASTLE CLINIC INC (NPI: 1801964960; TIN: 351188458) and primary practice location at 47304-6358. Davisson is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Davisson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 428 traditional Medicare patients, billed 4,113 HCPCS/CPT codes, and received $121,610 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 640 prescription claims across 258 beneficiaries totaling $9,125 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2021 DME data shows 28 claims. Open Payments data shows 71 records totaling $18,705. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $8,044 to $121,610. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,861 and ending at $9,125. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	65	138	$8,044
2020	364	1,285	$94,760
2021	336	1,091	$105,494
2022	364	1,153	$99,295
2023	370	3,508	$113,355
2024	428	4,113	$121,610

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	16	33	$1,861
2016	28	138	$7,976
2017	18	80	$7,504
2018	N/R	33	$4,726
2019	28	62	$3,128
2020	209	507	$11,763
2021	219	514	$6,730
2022	192	472	$10,148
2023	240	526	$24,908
2024	258	640	$9,125

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	24	24	$7,805
2021	28	28	$7,775
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	78	95	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	110	147	$89
62323	Injection of substance into lower spine canal using imaging guidance	101	114	$67
20610	Aspiration and/or injection of fluid from large joint	91	109	$36
77002	Fluoroscopic guidance for needle placement	72	85	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	211	2,143	$1,525
Celecoxib	Celecoxib	25	854	$998
Pregabalin	Pregabalin	43	1,590	$705
Gabapentin	Gabapentin	77	2,880	$455
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	292	$345

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	71	$18,705	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Mark Davisson, M.D.?

Tedicare shows public-source Medicare data for Andrew Mark Davisson, M.D. (NPI 1912385196), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Mark Davisson, M.D. have ACO affiliation data?

Andrew Mark Davisson, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Andrew Mark Davisson, M.D.?

Andrew Mark Davisson, M.D. is linked to NEW CASTLE CLINIC INC (billing NPI 1801964960) in the available physician profile data.

Does Andrew Mark Davisson, M.D. have Open Payments data?

Andrew Mark Davisson, M.D. has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.